HCV NS3 protease inhibitors

Details for Australian Patent Application No. 2006242475 (hide)

Owner Merck Sharp & Dohme Corp.

Inventors McCauley, John A.; Ludmerer, Steven W.; Olsen, David B.; Holloway, M. Katharine; Liverton, Nigel J.; Vacca, Joseph P.; Rudd, Michael T.

Agent Spruson & Ferguson

Pub. Number AU-B-2006242475

PCT Pub. Number WO2006/119061

Priority 60/676,806 02.05.05 US

Filing date 28 April 2006

Wipo publication date 9 November 2006

Acceptance publication date 7 July 2011

International Classifications

A61K 38/05 (2006.01) Medicinal preparations containing peptides - Dipeptides

A61K 38/12 (2006.01) Medicinal preparations containing peptides - Cyclic peptides

A61P 31/14 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

15 November 2007 PCT application entered the National Phase

  PCT publication WO2006/119061 Priority application(s): WO2006/119061

28 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

7 July 2011 Application Accepted

  Published as AU-B-2006242475

3 November 2011 Standard Patent Sealed

11 October 2012 Alteration of Name

  The name of the patentee has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006242476-Sclerostin epitopes

2006242473-Thermoplastic elastomer blend, method of manufacture and use thereof